As of November 2024, Mycenax Biotech has a market cap of $302.97M. This makes Mycenax Biotech the world's 14669th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $249.52M | 8.54% |
2023 | $229.88M | -4.80% |
2022 | $241.47M | -1.06% |
2021 | $244.05M | 17.70% |
2020 | $207.35M | 38.20% |
2019 | $150.04M | -9.69% |
2018 | $166.13M | -2.09% |
2017 | $169.68M | -22.50% |
2016 | $218.94M | -29.46% |
2015 | $310.37M | -14.08% |
2014 | $361.25M | -20.54% |
2013 | $454.62M | 143.45% |
2012 | $186.74M | - |